GUGGENHIME ANDREW
SEC CIK 1230724 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | Pres, CFO | 95.3K | — | $18.70M | 86 | 2021-11-18 | 2026-09-08 |
Most active insiders at PCVX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PICKERING GRANT | CEO, Dir | — | $3.63M |
| 2 | GUGGENHIME ANDREW | Pres AND CFO | — | $1.64M |
| 3 | Wassil Jim | EVP, COO, Chief Scientific Ofc | — | $1.43M |
| 4 | Dhaliwal Harpreet S. | Chief Technical Ops Off | — | $1.39M |
| 5 | Cowan Elvia | SVP, Fin | — | $988.6K |
| 6 | Jodar Luis | Chief Medical Off | — | — |
| 7 | Lee Jacks | Dir | — | — |
| 8 | Loxam Teri | Dir | — | — |
| 9 | Furey John | Dir | — | — |
| 10 | Paya Carlos V | Dir | — | — |
Transactions 86
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 17:54 | 2026-09-08 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $60.36 | -7,155 | 95.3K | -7% | -$431.9K | |
| M | 2026-09-02 19:56 | 2026-08-31+ | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $61.18 | -2,705 | 102.5K | -3% | -$165.5K |
| DT | 2026-08-05 16:58 | 2026-08-03 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +10.0K | 115.2K | +10% | +$53.5K |
| DMT | 2026-08-05 16:58 | 2026-08-03 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $53.89 | -10.0K | 105.2K | -9% | -$538.9K |
| DT | 2026-07-06 19:31 | 2026-07-06 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +10.0K | 114.4K | +10% | +$53.5K |
| DMT | 2026-07-06 19:31 | 2026-07-06 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $57.28 | -10.0K | 104.4K | -9% | -$572.8K |
| DT | 2026-06-18 20:07 | 2026-06-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +10.0K | 114.4K | +10% | +$53.5K |
| DT | 2026-06-18 20:07 | 2026-06-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $53.00 | -10.0K | 104.4K | -9% | -$530.0K |
| 2026-03-11 | 2026-03-09 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $59.32 | -1,021 | 104.4K | -1.0% | -$60.6K | |
| DM | 2026-03-02 | 2026-02-28+ | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $61.98 | -1,907 | 106.4K | -2% | -$118.2K |
| D | 2026-03-02 | 2026-02-26 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | A - Grant | $0.00 | +44.9K | 107.3K | +72% | $0 |
| I | 2026-01-16 | 2026-01-14 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | G - Gift | $0.00 | +61.9K | 61.9K | New | $0 |
| 2026-01-16 | 2026-01-14 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | G - Gift | $0.00 | -61.9K | 62.5K | -50% | $0 | |
| 2025-09-10 | 2025-09-08 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $32.41 | -2,890 | 124.3K | -2% | -$93.7K | |
| M | 2025-09-04 | 2025-09-02 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $31.56 | -5,080 | 131.0K | -4% | -$160.3K |
| D | 2025-04-09 | 2025-04-07 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $20.93 | +4,777 | 131.9K | +4% | +$100.0K |
| D | 2025-03-03 | 2025-02-27 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | A - Grant | $0.00 | +22.8K | 132.3K | +21% | $0 |
| DM | 2025-03-03 | 2025-02-28+ | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $72.33 | -5,079 | 131.0K | -4% | -$367.4K |
| D | 2025-02-19 | 2025-02-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 117.5K | +7% | +$42.8K |
| DM | 2025-02-19 | 2025-02-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $83.85 | -8,000 | 109.5K | -7% | -$670.8K |
| D | 2025-01-22 | 2025-01-21 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 117.5K | +7% | +$42.8K |
| DM | 2025-01-22 | 2025-01-21 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $86.51 | -8,000 | 109.5K | -7% | -$692.1K |
| DM | 2024-12-19 | 2024-12-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $88.78 | -8,000 | 109.8K | -7% | -$710.2K |
| D | 2024-12-19 | 2024-12-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 117.5K | +7% | +$42.8K |
| D | 2024-11-19 | 2024-11-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 117.5K | +7% | +$42.8K |
| DM | 2024-11-19 | 2024-11-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $85.82 | -8,000 | 109.5K | -7% | -$686.6K |
| D | 2024-10-28 | 2024-10-25 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $20.93 | +19.1K | 109.5K | +21% | +$399.9K |
| DM | 2024-10-22 | 2024-10-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +42.0K | 132.4K | +46% | +$224.7K |
| DM | 2024-10-22 | 2024-10-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $115.39 | -42.0K | 96.3K | -30% | -$4.85M |
| DM | 2024-09-19 | 2024-09-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $115.95 | -8,000 | 90.4K | -8% | -$927.6K |
| D | 2024-09-19 | 2024-09-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 98.4K | +9% | +$42.8K |
| 2024-09-05 | 2024-09-03 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $110.15 | -6,337 | 90.4K | -7% | -$698.0K | |
| D | 2024-08-20 | 2024-08-19 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 104.7K | +8% | +$42.8K |
| DM | 2024-08-20 | 2024-08-19 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $78.58 | -8,000 | 99.7K | -7% | -$628.7K |
| DM | 2024-07-22 | 2024-07-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $81.17 | -8,000 | 99.1K | -7% | -$649.4K |
| D | 2024-07-22 | 2024-07-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 104.7K | +8% | +$42.8K |
| DM | 2024-06-20 | 2024-06-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $71.92 | -8,000 | 96.7K | -8% | -$575.4K |
| D | 2024-06-20 | 2024-06-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 104.7K | +8% | +$42.8K |
| D | 2024-05-22 | 2024-05-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 103.7K | +8% | +$42.8K |
| DM | 2024-05-22 | 2024-05-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $74.99 | -8,000 | 100.1K | -7% | -$599.9K |
| DM | 2024-04-22 | 2024-04-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $61.27 | -8,000 | 95.7K | -8% | -$490.2K |
| D | 2024-04-22 | 2024-04-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 103.7K | +8% | +$42.8K |
| DM | 2024-03-20 | 2024-03-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $69.02 | -8,000 | 95.7K | -8% | -$552.2K |
| D | 2024-03-20 | 2024-03-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 103.7K | +8% | +$42.8K |
| D | 2024-03-04 | 2024-02-29 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | A - Grant | $0.00 | +20.0K | 99.5K | +25% | $0 |
| D | 2024-03-04 | 2024-03-02 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | F - Tax | $71.55 | -3,795 | 95.7K | -4% | -$271.5K |
| DM | 2024-02-22 | 2024-02-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $74.53 | -8,000 | 79.8K | -9% | -$596.2K |
| D | 2024-02-22 | 2024-02-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 87.5K | +10% | +$42.8K |
| DM | 2024-01-19 | 2024-01-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | S - Sale+OE | $60.74 | -8,000 | 80.0K | -9% | -$485.9K |
| D | 2024-01-19 | 2024-01-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres AND CFO | M - OptEx | $5.35 | +8,000 | 87.5K | +10% | +$42.8K |
| DM | 2023-12-20 | 2023-12-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $60.18 | -8,000 | 79.6K | -9% | -$481.4K |
| D | 2023-12-20 | 2023-12-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +8,000 | 87.5K | +10% | +$42.8K |
| D | 2023-12-18 | 2023-12-14 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +14.0K | 93.5K | +18% | +$74.9K |
| D | 2023-12-18 | 2023-12-14 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $60.22 | -14.0K | 79.5K | -15% | -$843.1K |
| DM | 2023-11-22 | 2023-11-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $51.13 | -8,000 | 79.6K | -9% | -$409.1K |
| D | 2023-11-22 | 2023-11-20 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +8,000 | 87.5K | +10% | +$42.8K |
| DM | 2023-10-20 | 2023-10-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $45.92 | -8,000 | 79.5K | -9% | -$367.3K |
| D | 2023-10-20 | 2023-10-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +8,000 | 87.5K | +10% | +$42.8K |
| 2023-09-06 | 2023-09-05 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | F - Tax | $51.00 | -3,568 | 79.5K | -4% | -$182.0K | |
| D | 2023-03-03 | 2023-03-01 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | A - Grant | $0.00 | +22.5K | 83.7K | +37% | $0 |
| D | 2023-03-03 | 2023-03-02 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | F - Tax | $41.49 | -1,727 | 82.0K | -2% | -$71.7K |
| D | 2023-01-04 | 2022-12-30 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +23.7K | 61.2K | +63% | +$126.7K |
| DM | 2022-09-21 | 2022-09-19 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $26.10 | -3,100 | 37.5K | -8% | -$80.9K |
| D | 2022-09-21 | 2022-09-19 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 40.6K | +8% | +$16.6K |
| 2022-09-07 | 2022-09-02 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | F - Tax | $26.38 | -4,649 | 37.5K | -11% | -$122.6K | |
| DM | 2022-08-29 | 2022-08-25+ | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +36.0K | 59.8K | +151% | +$192.6K |
| DM | 2022-08-29 | 2022-08-25+ | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $28.00 | -36.0K | 42.2K | -46% | -$1.01M |
| D | 2022-08-22 | 2022-08-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| DM | 2022-08-22 | 2022-08-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $25.26 | -3,100 | 42.2K | -7% | -$78.3K |
| DM | 2022-07-20 | 2022-07-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.53 | -3,100 | 42.2K | -7% | -$76.0K |
| D | 2022-07-20 | 2022-07-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| D | 2022-07-12 | 2022-07-08 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| D | 2022-07-12 | 2022-07-08 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -3,100 | 42.2K | -7% | -$74.4K |
| DM | 2022-05-20 | 2022-05-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.44 | -3,100 | 42.8K | -7% | -$75.8K |
| D | 2022-05-20 | 2022-05-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 45.3K | +7% | +$16.6K |
| D | 2022-04-20 | 2022-04-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 43.7K | +8% | +$16.6K |
| D | 2022-04-20 | 2022-04-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.05 | -3,100 | 40.6K | -7% | -$74.6K |
| D | 2022-03-22 | 2022-03-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $26.13 | -3,100 | 40.6K | -7% | -$81.0K |
| D | 2022-03-22 | 2022-03-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 43.7K | +8% | +$16.6K |
| D | 2022-03-04 | 2022-03-02 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | A - Grant | $0.00 | +37.5K | 40.6K | +1,200% | $0 |
| D | 2022-03-03 | 2022-03-01 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +6,200 | 9,325 | +198% | +$33.2K |
| D | 2022-03-03 | 2022-03-01 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -6,200 | 3,125 | -66% | -$148.8K |
| D | 2021-12-28 | 2021-12-23 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 6,225 | +99% | +$16.6K |
| D | 2021-12-28 | 2021-12-23 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.00 | -3,100 | 3,125 | -50% | -$74.4K |
| DM | 2021-11-22 | 2021-11-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | S - Sale+OE | $24.53 | -3,100 | 3,240 | -49% | -$76.0K |
| D | 2021-11-22 | 2021-11-18 | PCVX | Vaxcyte, Inc. | GUGGENHIME ANDREW | Pres, CFO | M - OptEx | $5.35 | +3,100 | 6,225 | +99% | +$16.6K |
Purchase Sale Sale after option exercise All abbreviations